Sarah Krüg is the CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is also the founder of the Health Collaboratory, a global innovations hub that paves the path for participatory co-design and collaboration in healthcare, and focused on amplifying the voice of the patient and caregiver in the design, development and continuous improvement of innovations. Through the Patient Shark Tank ®, over 16,000 patients and caregivers across disease states have evaluated over 700 innovations across the globe, including research, technology, and education. In addition, The Health Collaboratory has implemented participatory co-design with patients and caregivers to launch innovations such as Prescription to Learn. She is the Executive Director and Past President of the Society for Participatory Medicine, a patient: clinician member driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals. Sarah serves on the board of the National Organization for Rare Disorders and is Research Chair of the Cancer Education Network.
She previously held the position of Global Education Director in the Medical Education Group at Pfizer, as well as patient advocacy relations. She also established the Global Investigator Initiated Research Program at Pfizer. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.
Return to view more FutureLink Chicago speakers